Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

MDS 2021 | DBS as a treatment for dystonia

Andrea Kühn • 7 Sep 2021
MDS 2021
Movement Disorders

Andrea Kühn, MD, PhD, Charité – University Medicine Berlin, Berlin, Germany, talks on the role of deep brain stimulation (DBS) in dystonia treatment. Large scale trials have shown DBS treatment to be successful, particularly for generalized or segmental dystonia, but also focal dystonia. Analyses have revealed that younger patients with a shorter disease duration show the best responses. This interview took place during the 2021 International Congress of Parkinson’s Disease and Movement Disorders.

Disclosures

Prof. Kühn reports the following disclosures:
Honoraria for lectures and consultancies: Medtronic and Boston Scientific
Advisory Board: Medtronic

More from Andrea Kühn

1:43
The future of neuromodulation strategies in movement disorders
Andrea Kühn • 7 Sep 2021
1:59
Developments in DBS at MDS 2021
Andrea Kühn • 7 Sep 2021

Related Videos

1:19
The potential of cell and gene therapy in treating Parkinson’s disease
Fabrizio Stocchi • 7 Mar 2024
4:11
Updates on current Parkinson’s disease clinical trials
Fabrizio Stocchi • 7 Mar 2024
3:42
NfL shows strong prognostic value in pre-manifest Huntington's disease
Natalia E. Owen • 8 Mar 2024
5:26
Pridopidine shows benefit for patients with early HD not on antidopaminergic therapies
Michael Hayden • 16 Apr 2024
The content of VJNeurology is intended for healthcare professionals